Meds & supplements › Entecavir
Medicine
Entecavir tablets are indicated for the treatment of chronic hepatitis B virus infection in adults and pediatric patients 2 years of age and older with evidence of active viral replication and either evidence of persistent elevations in…
Selected manufacturer label information, organised into consistent sections by Sofidex. Read the full label at DailyMed ↗
These highlights do not include all the information needed to use ENTECAVIR TABLETS safely and effectively. See full prescribing information for ENTECAVIR TABLETS. Initial U.S. Approval: 2005 FULL PRESCRIBING INFORMATION WARNING: SEVERE ACUTE EXACERBATIONS OF HEPATITIS B, PATIENTS CO-INFECTED WITH HIV AND HBV, and LACTIC ACIDOSIS AND HEPATOMEGALY Severe acute exacerbations of hepatitis B have been reported in patients who have discontinued anti-hepatitis B therapy, including entecavir. Hepatic function should be monitored closely with both clinical and laboratory follow-up for at least several months in patients who discontinue anti-hepatitis B therapy. If appropriate, initiation of anti-hepatitis B therapy may be warranted. Limited clinical experience suggests there is a potential for the development of resistance to HIV (human immunodeficiency virus) nucleoside reverse transcriptase inhibitors if entecavir tablets are used to treat chronic hepatitis B virus (HBV) infection in patients with HIV infection that is not being treated. Therapy with entecavir tablets are not recommended for HIV/HBV co-infected patients who are not also receiving highly active antiretroviral therapy (HAART). Lactic acidosis and severe hepatomegaly with steatosis, including fatal cases, have been reported with the use of nucleoside analogue inhibitors alone or in combination with antiretrovirals. HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ENTECAVIR TABLETS safely and effectively. ENTECAVIR tablets, for oral use Initial U.S. Approval: 2005 WARNING: SEVERE ACUTE EXACERBATIONS OF HEPATITIS B, PATIENTS CO-INFECTED WITH HIV AND HBV, and LACTIC ACIDOSIS AND HEPATOMEGALY See full prescribing information for complete boxed warning. ● Severe acute exacerbations of hepatitis B have been reported in patients who have discontinued anti-hepatitis B therapy, including entecavir. Hepatic function should be monitored closely for at least several months after discontinuation. Initiation of anti-hepatitis B therapy may be warranted. ● Entecavir tablets are not recommended for patients co-infected with human immunodeficiency virus (HIV) and hepatitis B virus (HBV) who are not also receiving highly active antiretroviral therapy (HAART), because of the potential for the development of resistance to HIV nucleoside reverse transcriptase inhibitors. ● Lactic acidosis and severe hepatomegaly with steatosis, including fatal cases, have been reported with the use of nucleoside analogue inhibitors.
Entecavir tablets are a prescription medicine used to treat chronic hepatitis B virus (HBV) in adults and children 2 years of age and older who have active liver disease.
Entecavir tablets will not cure HBV. ● Entecavir tablets may lower the amount of HBV in the body. ● Entecavir tablets may lower the ability of HBV to multiply and infect new liver cells. ● Entecavir tablets may improve the condition of your liver. ● It is not known whether entecavir tablets will reduce your chances of getting liver cancer or liver damage (cirrhosis), which may be caused by chronic HBV infection.
It is not known if entecavir tablets are safe and effective for use in children less than 2 years of age.
1. Your hepatitis B virus (HBV) infection may get worse if you stop taking entecavir tablets. This usually happens within 6 months after stopping entecavir tablets. ● Take entecavir tablets exactly as prescribed. ● Do not run out of entecavir tablets. ● Do not stop entecavir without talking to your healthcare provider. ● Your healthcare provider should monitor your health and do regular blood tests to check your liver if you stop taking entecavir tablets.
2. If you have or get HIV that is not being treated with medicines while taking entecavir tablets, the HIV virus may develop resistance to certain HIV medicines and become harder to treat. You should get an HIV test before you start taking entecavir tablets and anytime after that when there is a chance you were exposed to HIV.
Entecavir tablets can cause serious side effects including:
3. Lactic acidosis (buildup of acid in the blood). Some people who have taken entecavir tablets or medicines like entecavir tablets (a nucleoside analogue) have developed a serious condition called lactic acidosis. Lactic acidosis is a serious medical emergency that can cause death. Lactic acidosis must be treated in the hospital. Reports of lactic acidosis with entecavir tablets generally involved patients who were seriously ill due to their liver disease or other medical condition.
Call your healthcare provider right away if you get any of the following signs or symptoms of lactic acidosis: ● You feel very weak or tired. ● You have unusual (not normal) muscle pain. ● You have trouble breathing. ● You have stomach pain with nausea and vomiting. ● You feel cold, especially in your arms and legs. ● You feel dizzy or light-headed. ● You have a fast or irregular heartbeat.
4. Serious liver problems. Some people who have taken medicines like entecavir tablets have developed serious liver problems called hepatotoxicity, with liver enlargement (hepatomegaly) and fat in the liver (steatosis). Hepatomegaly with steatosis is a serious medical emergency that can cause death.
Call your healthcare provider right away if you get any of the following signs or symptoms of liver problems:
Your skin or the white part of your eyes turns yellow (jaundice). ● Your urine turns dark. ● Your bowel movements (stools) turn light in color. ● You don’t feel like eating food for several days or longer. ● You feel sick to your stomach (nausea). ● You have lower stomach pain.
You may be more likely to get lactic acidosis or serious liver problems if you are female, very overweight, or have been taking nucleoside analogue medicines, like entecavir tablets, for a long time.
Take entecavir tablets exactly as your healthcare provider tells you to. ● Your healthcare provider will tell you how much entecavir tablets to take. ● Your healthcare provider will tell you when and how often to take entecavir tablets. ● Take entecavir tablets on an empty stomach, at least 2 hours after a meal and at least 2 hours before the next meal.
Do not change your dose or stop taking entecavir tablets without talking to your healthcare provider.
If you miss a dose of entecavir tablets, take it as soon as you remember and then take your next dose at its regular time. If it is almost time for your next dose, skip the missed dose. Do not take two doses at the same time. Call your healthcare provider or pharmacist if you are not sure what to do. ● When your supply of entecavir tablets starts to run low, call your healthcare provider or pharmacy for a refill. Do not run out of entecavir tablets.
If you take too much entecavir tablets, call your healthcare provider or go to the nearest emergency room right away.
Entecavir tablets may cause serious side effects. The most common side effects of entecavir tablets include: ● headache ● tiredness ● dizziness ● nausea
Tell your healthcare provider if you have any side effect that bothers you or that does not go away. These are not all the possible side effects of entecavir tablets. For more information, ask your healthcare provider or pharmacist.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
Before you take entecavir tablets, tell your healthcare provider if you: ● have kidney problems. Your entecavir tablets dose or schedule may need to be changed. ● have received medicine for HBV before. Some people, especially those who have already been treated with certain other medicines for HBV infection, may develop resistance to entecavir tablets. These people may have less benefit from treatment with entecavir tablets and may have worsening of hepatitis after resistant virus appears. Your healthcare provider will test the level of the hepatitis B virus in your blood regularly.
have any other medical conditions. ● are pregnant or plan to become pregnant. It is not known if entecavir will harm your unborn baby. Talk to your healthcare provider if you are pregnant or plan to become pregnant.
Antiretroviral Pregnancy Registry. If you take entecavir tablets while you are pregnant, talk to yourhealthcare provider about how you can take part in the Entecavir Antiretroviral Pregnancy Registry. The purpose of the pregnancy registry is to collect information about the health of you and your baby. ● are breastfeeding or plan to breastfeed. It is not known if entecavir can pass into your breast milk. You and your healthcare provider should decide if you will take entecavir tablets or breastfeed.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Especially tell your healthcare provider if you have taken a medicine to treat HBV in the past.
Know the medicines you take. Keep a list of your medicines with you to show your healthcare provider and pharmacist when you get a new medicine.
Store entecavir tablets at room temperature, between 68° F to 77° F (20° C to 25° C). ● Keep entecavir tablets in a tightly closed container and keep out of the light. ● Safely throw away entecavir tablets that are out of date or no longer needed. Dispose of unused medicines through communitytake-back disposal programs when available or place entecavir tablets in an unrecognizable closed container in the household trash. Keep entecavir tablets and all medicines out of the reach of children.
General information about the safe and effective use of entecavir tablets.
Entecavir tablets do not stop you from spreading the hepatitis B virus (HBV) to others by sex, sharing needles, or being exposed to your blood. Talk with your healthcare provider about safe sexual practices that protect your partner. Never share needles. Do not share personal items that can have blood or body fluids on them, like toothbrushes or razor blades. A shot (vaccine) is available to protect people at risk from becoming infected with HBV.
Medicines are sometimes prescribed for purposes other than those listed in a patient information leaflet. Do not use entecavir tablets for a condition for which it was not prescribed. Do not give entecavir tablets to other people, even if they have the same symptoms you have. It may harm them.
This Patient Information Leaflet summarizes the most important information about entecavir tablets. If you would like more information, talk with your healthcare provider. You can ask your healthcare provider or pharmacist for information about entecavir tablets that is written for healthcare professionals. For more information, call 1-855-397-9777.
sofidex [Internet]. Daloreum; c2026. Entecavir; [reviewed 2026 Aug 2; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/medicines/entecavir
sofidex. (2026, August 2). Entecavir. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/medicines/entecavir
Entecavir. sofidex. Reviewed August 2, 2026. Accessed November 10, 2026. https://sofidex.com/patients/medicines/entecavir
The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.